Dedicated to the advancement of breakthrough medicine and treatments in psychedelics, reMind will host its debut event — The Psychedelics Business Forum — at MJBizCon New York, NY (6 Oct 2022) – Emerald Holding, Inc. today introduced reMind, a new media and events platform committed to building, connecting and educating diverse communities to responsibly grow […]
By Brad Dunn — Benjamin Lightburn has built a career on the belief that compounds extracted naturally from plants and fungi are superior to those synthesized in a lab. He and many of his colleagues at the botanical-extraction company Mazza Innovation exited in 2018, only to reunite in 2020 to launch Filament Health, where they […]
By Brad Dunn — In 2011, Pat Murphy was searching for a subject for his senior film project at New York University’s film school, when he overheard someone at a party talking about a new study at the NYU School of Medicine that was testing psilocybin to help cancer patients with end-of-life anxiety. The idea […]
By Brad Dunn Alzheimer’s disease — and the toll it took on both their father and grandfather — prompted Chris and Joe Claussen to make drastic career changes. Chris, a former commercial photographer, and Joe, a former charter-boat operator, spent years researching brain chemistry and experimenting with different diets and compounds to help their father. […]
By Brad Dunn — The Oregon Health Authority has published a draft of its proposed rules related to psilocybin users, facilitators, treatment centers and manufacturers as part of Measure 109. The 65-page draft released Thursday sets parameters for dosages, facilitator interactions, licensing rules, and social equity guidelines that will shape the state’s nascent psilocybin industry. […]
